USPTO serial 98494527
BRAINTRANSPORTER
Reviewed by CopyMark Law Group
Status 731Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- ALAO, OREOLUWA
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with BRAINTRANSPORTER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Stockholm, SE
Stockholm, SE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jessica S. Sachs
Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.100 Bloomfield Hills ParkwaySuite 200Bloomfield Hills, MI 48304Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | (Based on Intent to Use) Chemical substances, chemical materials and chemical preparations, and natural biological preparation elements for use in manufacture of pharmaceuticals; chemical substances and materials for industrial, scientific and laboratory use other than for medical or veterinary purposes; biochemical preparations for scientific purposes; biochemical substances being biochemical preparations for scientific purposes; chemical substances for use in the production of drugs, pharmaceuticals and antibodies; reagents for scientific, laboratory, analysis, research, medical research, testing, inspection, detecting or verification use other than for medical use; reagents other than for medical or veterinary purposes for use in the development of antibodies for scientific and medical research use; reagents for scientific or medical research use for use in scientific apparatus for chemical or biological analysis; stem cells and reconstituted cells for research or scientific purposes; reconstituted cells for the efficiency and tolerance testing of pharmaceutical products for research or scientific purposes; antibodies and antibodies-based chemicals, except for medical or veterinary use being antibodies and antibodies-based chemicals for scientific purposes; biological preparation for use in cell cultures other than for medical or veterinary use | ACTIVE | — |
| 005 | (Based on Intent to Use) Medical and veterinary preparations for the treatment of disorders of the central nervous system; Medical and veterinary articles namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; pharmaceutical preparations and substances for the treatment of disorders of the central nervous system; biochemical preparations for medical use for the treatment of the central nervous system; pharmaceutical preparations and medical preparations for the treatment, prevention and diagnosis of Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases and disorders of the central nervous system; antibodies and antibodies-based pharmaceutical preparations for medical purposes for diagnostic testing relating to disorders of the central nervous system; diagnostic preparations and materials for medical or veterinary purposes; medical therapeutic agents for the central nervous system; reagents for medical use; biochemical biomarkers for medical use; diagnostic biomarker reagents for medical purposes; (Based on Section 44(e)) (Based on Intent to Use) live organs and tissues for surgical implantation purpose; (Based on Intent to Use) cells for medical use; stem cells for medical purposes; (Based on Section 44(e)) (Based on Intent to Use) sanitary preparations for medial purposes; (Based on Intent to Use) dietetic substances, namely dietetic foods, adapted for medical purposes | ACTIVE | — |
| 042 | (Based on Intent to Use) scientific and technological services and research, namely, scientific research relating to product development and design in the field of central nervous system disorders; medical and pharmacological research services; medical, pharmaceutical and biotechnological laboratory research services; scientific investigations for medical purposes; conducting clinical trials for others; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; biochemical analysis and research; drug discovery services; pharmaceutical products development and evaluation | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 11, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 11, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 11, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 11, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 9, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 8, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 8, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 8, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 1, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 6, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 6, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 30, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 10, 2025 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Mar 28, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 12, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 12, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 19, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 19, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 19, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 21, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 21, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 13, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 22, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 11, 2024 | NWAP | NEW APPLICATION ENTERED | — |